US Patent 11229621 Pharmaceutical compositions of dimethyl fumarate
Patent 11229621 was granted and assigned to Arbor Pharmaceuticals on January, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+139 characters)
Article
Patent abstract
Pharmaceutical compositions and dosage forms of dimethyl fumarate containing low levels of certain impurities are disclosed.
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Sami Karaborni0
Suresh Kumar Manthati0
Wei Chen0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112296210
Date of Patent
January 25, 2022
0Patent Application Number
167494270
Date Filed
January 22, 2020
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11229621 Pharmaceutical compositions of dimethyl fumarate
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11229621
Date of patent
January 25, 2022
Patent application number
16749427
Date Filed
January 22, 2020
Patent primary examiner
Find more entities like US Patent 11229621 Pharmaceutical compositions of dimethyl fumarate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
